Health
Rutgers leading coronavirus therapeutic clinical trial – EurekAlert
Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with…
Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic. The trial is being conducted with Synavir Corporation, a global health company that works with academia, industry and government to develop combination treatments for new viral infections.
The trial — called Triple Combination Antiviral Coronavirus Therapy (TriACT) — seeks to determine…
-
Noosa News22 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News22 hours agoE-biker charged with riding dangerously, assaulting cop
-
Business15 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General21 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands